Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celator Pharmaceuticals Inc (NASDAQ:CPXX)

2.09
Delayed Data
As of Aug 28
 +0.05 / +2.45%
Today’s Change
1.58
Today|||52-Week Range
3.53
+6.63%
Year-to-Date
No recent news for Celator Pharmaceuticals Inc.

Today’s Trading

Previous close2.04
Today’s open2.05
Day’s range2.03 - 2.12
Volume96,124
Average volume (3 months)755,839
Market cap$69.0M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+34.74%
Earnings growth (this year)+5.38%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.14

Competitors

 Today’s
change
Today’s
% change
ORMPOramed Pharmaceutica...-0.10-1.68%
OCRXOcera Therapeutics I...+0.11+3.12%
CAPRCapricor Therapeutic...-0.04-0.93%
EBIOEleven Biotherapeuti...-0.08-2.20%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$16.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Scott T. Jackson
President &
Chief Scientific Officer
Lawrence David Mayer
Corporate headquarters
Ewing, New Jersey

Forecasts

Partner Offers